Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma
(2020) In Scientific Reports 10(1). p.11997-11997- Abstract
Neuroblastoma is the most common paediatric cancer type. Patients diagnosed with high-risk neuroblastoma have poor prognosis and occasionally tumours relapse. As a result, novel treatment strategies are needed for relapse and refractory neuroblastoma patients. Here, we found that high expression of Mps1 kinase (mitotic kinase Monopolar Spindle 1) was associated with relapse-free neuroblastoma patient outcomes and poor overall survival. Silencing and inhibition of Mps1 in neuroblastoma or PDX-derived cells promoted cell apoptosis via the caspase-dependent mitochondrial apoptotic pathway. The mechanism of cell death upon Mps1 inhibition was dependent on the polyploidization/aneuploidization of the cells before undergoing mitotic... (More)
Neuroblastoma is the most common paediatric cancer type. Patients diagnosed with high-risk neuroblastoma have poor prognosis and occasionally tumours relapse. As a result, novel treatment strategies are needed for relapse and refractory neuroblastoma patients. Here, we found that high expression of Mps1 kinase (mitotic kinase Monopolar Spindle 1) was associated with relapse-free neuroblastoma patient outcomes and poor overall survival. Silencing and inhibition of Mps1 in neuroblastoma or PDX-derived cells promoted cell apoptosis via the caspase-dependent mitochondrial apoptotic pathway. The mechanism of cell death upon Mps1 inhibition was dependent on the polyploidization/aneuploidization of the cells before undergoing mitotic catastrophe. Furthermore, tumour growth retardation was confirmed in a xenograft mouse model after Mps1-inhibitor treatment. Altogether, these results suggest that Mps1 expression and inhibition can be considered as a novel prognostic marker as well as a therapeutic strategy for the treatment of high-risk neuroblastoma patients.
(Less)
- author
- Simon Serrano, Sonia LU ; Sime, Wondossen LU ; Abassi, Yasmin LU ; Daams, Renée LU ; Massoumi, Ramin LU and Jemaà, Mohamed LU
- organization
- publishing date
- 2020-07-20
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Scientific Reports
- volume
- 10
- issue
- 1
- pages
- 11997 - 11997
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85088259209
- pmid:32686724
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-020-68829-y
- language
- English
- LU publication?
- yes
- additional info
- These authors jointly supervised this work: Ramin Massoumi and Mohamed Jemaà.
- id
- 0a5bf038-535f-45c3-a936-c0568e45c778
- date added to LUP
- 2020-07-22 12:43:21
- date last changed
- 2025-05-02 00:30:19
@article{0a5bf038-535f-45c3-a936-c0568e45c778, abstract = {{<p>Neuroblastoma is the most common paediatric cancer type. Patients diagnosed with high-risk neuroblastoma have poor prognosis and occasionally tumours relapse. As a result, novel treatment strategies are needed for relapse and refractory neuroblastoma patients. Here, we found that high expression of Mps1 kinase (mitotic kinase Monopolar Spindle 1) was associated with relapse-free neuroblastoma patient outcomes and poor overall survival. Silencing and inhibition of Mps1 in neuroblastoma or PDX-derived cells promoted cell apoptosis via the caspase-dependent mitochondrial apoptotic pathway. The mechanism of cell death upon Mps1 inhibition was dependent on the polyploidization/aneuploidization of the cells before undergoing mitotic catastrophe. Furthermore, tumour growth retardation was confirmed in a xenograft mouse model after Mps1-inhibitor treatment. Altogether, these results suggest that Mps1 expression and inhibition can be considered as a novel prognostic marker as well as a therapeutic strategy for the treatment of high-risk neuroblastoma patients.</p>}}, author = {{Simon Serrano, Sonia and Sime, Wondossen and Abassi, Yasmin and Daams, Renée and Massoumi, Ramin and Jemaà, Mohamed}}, issn = {{2045-2322}}, language = {{eng}}, month = {{07}}, number = {{1}}, pages = {{11997--11997}}, publisher = {{Nature Publishing Group}}, series = {{Scientific Reports}}, title = {{Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma}}, url = {{http://dx.doi.org/10.1038/s41598-020-68829-y}}, doi = {{10.1038/s41598-020-68829-y}}, volume = {{10}}, year = {{2020}}, }